Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly … – Nasdaq
|
Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly …
Nasdaq OCEANSIDE, Calif., May 31, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire — Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today their plans to provide access to its clinical stage cancer immunotherapy product StemVacs under … |
